Recurrent hepatocellular carcinoma after liver transplant: Identifying the high-risk patient

HPB

Volumn 13, Issue 9, 2011, Pages 626-632

  Nissen, Nicholas N ^a   Menon, Vijay ^a   Bresee, Catherine ^b   Tran, Tram T ^a   Annamalai, Alagappan ^a   Poordad, Fred ^a   Fair, Jeffrey H ^a   Klein, Andrew S ^a   Boland, Brendan ^a   Colquhoun, Steven D ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b Samuel J Oschin Comprehensive Cancer Institute   (United States)

Author keywords

hepatocellular carcinoma; indications < transplant; liver < transplant; outcomes < transplant

Indexed keywords

ADULT; CANCER STAGING; COHORT ANALYSIS; CONFERENCE PAPER; DISEASE FREE SURVIVAL; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREDICTION; RECURRENCE FREE SURVIVAL; RECURRENT CANCER; TREATMENT OUTCOME;

EID: 80051915645     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2011.00342.x     Document Type: Conference Paper

References (14)

1. Organ Procurement and Transplantation Network. Policies. [Accessed 1 July 2011.
2. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook P, et al,. (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33: 1394-1403. (Pubitemid 32496976)
3. Organ Procurement and Transplantation Network. Data available online at. [Accessed 1 July 2011.
4. Vivarelli M, Cucchetti A, Piscaglia F, La Barba G, Bolondi L, Cavallari A, et al,. (2005) Analyses of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. Liver Transpl 11: 497-503. (Pubitemid 40704060)
5. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al,. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693-699. (Pubitemid 26079803)
6. Mazzaferro V, Llovet J, Miceli R, Bhoori S, Schiavo M, Mariani L, et al,. (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10: 35-43.
7. Chinnakotla S, Davis GL, Vasani S, Kim P, Tomiyama K, Sanchez E, et al,. (2009) Impact of sirolimus on the recurrence of hepatocellular carcinoma after liver transplantation. Liver Transpl 15: 1834-1842.
8. Printz C,. (2009) Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM). Cancer 115: 4646.
9. Thuluvath PJ, Guidinger MK, Fung JJ, Johnson LB, Rayhill SC, Pelletier SJ., (2010) Liver transplantation in the United States, 1999-2008. Am J Transplant 10 (4 Pt 2): 1003-1019.
10. Merani A, Majno P, Kneteman NM, Berney T, Morel P, Mentha G, et al,. (2011) The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma. J Hepatol Feb 18 (Epub ahead of print).
11. Yao FY, Hirose R, LaBerge JM, Davern TJ 3rd, Bass NM, Kerlan RK Jr, et al,. (2005) A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 11: 1505-1514. (Pubitemid 43072626)
12. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al,. (2008) Sorafenib in advanced hepatocellular carcinoma. N Eng J Med 359: 378-390.
13. Duffy J, Vardanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM, et al,. (2007) Liver transplantation criteria for hepatocellular cancer should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 246: 509-511.
14. Onaca N, Klintmalm GB,. (2010) Liver transplantation for hepatocellular carcinoma: the Baylor experience. J Hepatobiliary Pancreat Sci 17: 574-580.